Litcius/Paper detail

An observer-blind, randomised, placebo-controlled, phase 1, single ascending dose study of dengue monoclonal antibody in healthy adults in Australia

Bhagwat Gunale, Nicholas Farinola, Chandrashekhar D. Kamat, Cyrus S. Poonawalla, Sambhaji S. Pisal, Rajeev Dhere, Claire A. Miller, Prasad S. Kulkarni

2024The Lancet Infectious Diseases25 citationsDOI

Topics & Concepts

MedicineDengue feverPlaceboCohortDengue virusInternal medicineDengue vaccineImmunologyPathologyAlternative medicineMosquito-borne diseases and controlBiological Research and Disease StudiesMalaria Research and Control
An observer-blind, randomised, placebo-controlled, phase 1, single ascending dose study of dengue monoclonal antibody in healthy adults in Australia | Litcius